Psychopharmacology

Barratt ES, Stanford MS, Felthous AR, & Kent TA. The effects of phenytoin on impulsive and premeditated aggression: A controlled study. Journal of Clinical Psychopharmacology. 1997 Oct;17(5):341-9.

Benedetti F, Sforzini L, Colombo C, et al. Low-dose clozapine in acute and continuation treatment of severe borderline personality disorder. Journal of Clinical Psychiatry. 1998 Mar;59(3):103-7.

Benjamin LS. Special feature: Personality disorders: Models for treatment and strategies for treatment development. Journal of Personality Disorders. 1997 Winter;11(4):307-24. Review.

Black KJ, & Sheline YI. Personality disorder scores improve with effective pharmacotherapy of depression. Journal of Affective Disorders. 1997 Mar;43(l):11-8.

Bohus MJ, Landwehrmeyer GB, Stiglmayr CE, et al. Naltrexone in the treatment of dissociative symptoms in patients with borderline personality disorder: An open-label trial. Journal of Clinical Psychiatry. 1999 Sep;60(9):598-603.

Chengappa KN, Ebeling T, Kang JS, et al. Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder. Journal of Clinical Psychiatry. 1999 Jul;60(7):477-84.

Coccaro EF. Clinical outcome of psychopharmacologic treatment of borderline and schizotypal personality disordered subjects. Journal of Clinical Psychiatry. 1998;59 Suppl 1:30-5; discussion 36-7. Review.

Coccaro EF, & Kavoussi RJ. Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Archives of General Psychiatry. 1997 Dec;54(12):1081-8.

Frankenburg FR, & Zanarini MC. Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: A double-blind placebo-controlled pilot study. The Journal of Clinical Psychiatry. 2002 May;63(5):442-6.

Hirschfeld RM. Pharmacotherapy of borderline personality disorder. Journal of Clinical Psychiatry. 1997;58 Suppl 14:48-52;discussion 53. Review.

Hollander E. Managing aggressive behavior in patients with obsessive-compulsive disorder and borderline personality disorder. Journal of Clinical Psychiatry. 1999;60 Suppl 15:38-44. Review.

Hollander E, Allen A, Lopez RP, et al. A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder. Journal of Clinical Psychiatry. 2001 Mar;62(3):199-203.

Kapfhammer HP, & Hippius H. Special feature: Pharmacotherapy in personality disorders. Journal of Personality Disorders. 1998 Fall;12(3):277-88. Review.

Koenigsberg HW, Reynolds D, Goodman M, et al. Risperidone in the treatment of schizotypal personality disorder. Journal of Clinical Psychiatry. 2003 Jun;64(6):628-34.

Links PS. Developing effective services for patients with personality disorders. Canadian Journal of Psychiatry. 1998 Apr;43(3):251-9. Review.

Links PS, Boggild A, & Sarin N. Psychopharmacology of personality disorders: Review and emerging issues. Current Psychiatry Reports. 2001 Feb;3(1):70-6. Review.

Rocca P, Marchiaro L, Cocuzza E, & Bogetto F. Treatment of borderline personality disorder with risperidone. The Journal of Clinical Psychiatry. 2002 Mar;63(3):241-4.

Soloff PH. Algorithms for pharmacological treatment of personality dimensions: Symptom-specific treatments for cognitive-perceptual, affective, and impulsive-behavioral dysregulation. Bulletin of the Menninger Clinic. 1998 Spring;62(2):195-214.

Soloff PH. Psychopharmacology of borderline personality disorder. Psychiatric Clinics of North America. 2000 Mar;23(1):169-192, ix. Review.

Teusch L, Bohme H, & Finke J. Effects of client-centered psychotherapy for personality disorders alone and in combination with psychopharmacological treatment. An empirical follow-up study. Psychotherapy and Psychosomatics. 2001 Nov-Dec;70(6):328-36.

Verhoeven WM, & Tuinier S. Two steps forward, one step back; Paradigmatic changes in psychiatry. Journal of Neural Transmission. 2001; 108(6):617-27.

Verkes RJ, et al. Reduction by paroxetine of suicidal behavior in patients with repeated suicide attempts but not major depression. American Journal of Psychiatry. 1998 Apr;155(4):543-7.

Villalba R, & Harrington CJ. Repetitive self-injurious behavior: A neuropsychiatric perspective and review of pharmacologic treatments. Seminars in Clinical Neuropsychiatry. 2000 Oct;5(4):215-26. Review.